Métricas em artrite reumatoide: uma revisão para a prática clínica
暂无分享,去创建一个
[1] P. Louzada-Junior,et al. Performance of the Rheumatoid Arthritis Disease Activity Index in the Assessment of Disease Activity in Rheumatoid Arthritis—Findings From the REAL Study , 2022, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[2] Max Victor Carioca de Freitas,et al. Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis , 2021, Advances in Rheumatology.
[3] Lara A. Kahale,et al. Using Parallel Streams of Evidence to Inform Guideline Development: The Case of the 2021 American College of Rheumatology Management of Rheumatoid Arthritis Guideline , 2021, ACR open rheumatology.
[4] H. Bliddal,et al. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial , 2019, JAMA.
[5] K. Michaud,et al. Correlation of the Multi‐Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta‐Analysis , 2019, Arthritis care & research.
[6] Matthias Schneider,et al. Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort , 2017, BMC Musculoskeletal Disorders.
[7] M. Dougados,et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis , 2017, Annals of the rheumatic diseases.
[8] Inge Christoffer Olsen,et al. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial , 2016, British Medical Journal.
[9] D. M. van der Heijde,et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial , 2016, Annals of the rheumatic diseases.
[10] Yoshiya Tanaka,et al. Assessment of disease activity in rheumatoid arthritis by multi-biomarker disease activity (MBDA) score. , 2016, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.
[11] P. Emery,et al. Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial , 2013, Annals of the rheumatic diseases.
[12] J. Carulli,et al. Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis , 2013, PloS one.
[13] H. H. Kuper,et al. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry , 2011, Annals of the rheumatic diseases.
[14] M. Weinblatt,et al. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort , 2011, Annals of the rheumatic diseases.
[15] M. Tomšič,et al. Clinical contrasts with the American College of Rheumatology/European League Against Rheumatism provisional definitions of remission in rheumatoid arthritis for clinical trials: Comment on the article by Felson et al. , 2011, Arthritis and rheumatism.
[16] W. Taylor,et al. The Patient Activity Scale-II Is a Generic Indicator of Active Disease in Patients with Rheumatic Disorders , 2010, The Journal of Rheumatology.
[17] T. Pincus,et al. RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories , 2008, The Journal of Rheumatology.
[18] J. Smolen,et al. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. , 2007, Best practice & research. Clinical rheumatology.
[19] Désirée van der Heijde,et al. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response. , 2007, Arthritis and rheumatism.
[20] J J Anderson,et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[21] M. Prevoo,et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[22] M. A. van 't Hof,et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. , 1990, Annals of the rheumatic diseases.
[23] D. Heijde,et al. EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITIS , 1989, The Lancet.
[24] J. Moreland,et al. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. , 1971, Arthritis and rheumatism.